Evidence map›Paper›PMID 34442719›Full record

ArticleMicroorganisms2021

Bonsecamin: A New Cyclic Pentapeptide Discovered through Heterologous Expression of a Cryptic Gene Cluster.

Constanze Lasch, Marc Stierhof, Marta Rodríguez Estévez, Maksym Myronovskyi, Josef Zapp, Andriy Luzhetskyy

Abstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Synthetic and systems biotechnology · 2026
    Review
  2. Review
  3. Article
  4. Bacterial natural product discovery by heterologous expression.Journal of industrial microbiology & biotechnology · 2023
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Constanze LaschDepartment of Pharmaceutical Biotechnology, Saarland University, 66123 Saarbruecken, Germany.
Marc StierhofDepartment of Pharmaceutical Biotechnology, Saarland University, 66123 Saarbruecken, Germany.
Marta Rodríguez EstévezDepartment of Pharmaceutical Biotechnology, Saarland University, 66123 Saarbruecken, Germany.
Maksym MyronovskyiDepartment of Pharmaceutical Biotechnology, Saarland University, 66123 Saarbruecken, Germany.
Josef ZappDepartment of Pharmaceutical Biology, Saarland University, 66123 Saarbruecken, Germany.
Andriy LuzhetskyyDepartment of Pharmaceutical Biotechnology, Saarland University, 66123 Saarbruecken, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intriguing structural complexity of molecules produced by natural organisms is uncontested. Natural scaffolds serve as an important basis for the development of molecules with broad applications, e.g., therapeutics or agrochemicals. Research in recent decades has demonstrated that by means of classic metabolite extraction from microbes only a small portion of natural products can be accessed. The use of genome mining and heterologous expression approaches represents a promising way to discover new natural compounds. In this paper we report the discovery of a novel cyclic pentapeptide called bonsecamin through the heterologous expression of a cryptic NRPS gene cluster from

Indexed as

cyclic peptideheterologous expressionNRPSStreptomyces

Identifiers

PMID34442719
PMCPMC8400726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.